JiaLuoMD

PubMed

• Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With-Mutated Non-Small Cell Lung Cancer: A Case Series and Literature Review.
  Anjali Donnelly, Kevin Lu, Debra Ryan, Jia Luo, Narjust Florez, Yanyan Lou, Patrick C Ma, Alexander I Spira, Hatim Husain> ;JCO Precision Oncology. 2024 Apr 1
• Safety and Intracranial Activity of Adagrasib in Patients With-Mutated Non-Small-Cell Lung Cancer and Untreated CNS Metastases in the KRYSTAL-1 Trial: A Case Series.
  Bernstein, E., Wang, K., Jänne, P., Luo, J., Negrao, M., Sabari, J.> ;JCO Precision Oncology. 2024 Feb 1
• 3 citations
  Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer.
  Danish Memon, Adam J Schoenfeld, Darwin Ye, George Fromm, Hira Rizvi, Xiang Zhang, Mohamed Reda Keddar, Divij Mathew, Kyung Jin Yoo, Jingya Qiu, Jayon Lihm, Jayalaksmi...> ;Cancer Cell. 2024 Feb 12
• NovelFusion in NUT Carcinoma With Exceptional Response to Chemotherapy: A Case Report.
  Kim, J., Huang, Y., Durall, R., Becker, S., Canty, S., Molinaro, S., Shapiro, G., Wu, S., Pisick, E., French, C., Luo, J.> ;JTO Clinical and Research Reports. 2024 Jan 1
• 1 citations
  Initial Chemotherapy for Locally Advanced and Metastatic NUT Carcinoma.
  Luo, J., Sanchez, M., Lee, E., Hertzler, H., Luong, N., Mazzola, E., Finstein, B., Tamen, R., Brisbane, G., Nguyen, T., Paik, P., Chaft, J., Cheng, M., Khalil, H., Pih...> ;Journal of Thoracic Oncology. 2023 Dec 27
• 1 citations
  Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial.
  Desai, J., Alonso, G., Kim, S., Cervantes, A., Karasic, T., Medina, L., Shacham-Shmueli, E., Cosman, R., Falcon, A., Gort, E., Guren, T., Massarelli, E., Miller, W., P...> ;Nature Medicine. 2024 Jan 1
• 4 citations
  Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLC.
  Vaz, V., Joao V Alessi, Xinan Wang, Arielle Elkrief, Biagio Ricciuti, Yvonne Y Li, Hersh Gupta, Liam F Spurr, Hira Rizvi, Jia Luo, Federica Pecci, Giuseppe Lamberti, G...> ;Journal of Thoracic Oncology. 2023 Nov 1
• 2 citations
  The BRD4-NUT Fusion Alone Drives Malignant Transformation of NUT Carcinoma.
  R Taylor Durall, Julianna Huang, Luke Wojenski, Yeying Huang, Prafulla C Gokhale, Brittaney A Leeper, Joshua O Nash, Pedro L Ballester, Scott Davidson, Adam Shlien, Em...> ;Cancer Research. 2023 Dec 1
• EZH2 Cooperates with BRD4-NUT to Drive NUT Carcinoma Growth by Silencing Key Tumor Suppressor Genes.
  Yeying Huang, R Taylor Durall, Nhi M Luong, Hans J Hertzler, Julianna Huang, Prafulla C Gokhale, Brittaney A Leeper, Nicole S Persky, David E Root, Praju V Anekal, Pau...> ;Cancer Research. 2023 Dec 1
• 1 citations
  EZH2 synergizes with BRD4-NUT to drive NUT carcinoma growth through silencing of key tumor suppressor genes.
  Yeying Huang, R Taylor Durall, Nhi M Luong, Hans J Hertzler, Julianna Huang, Prafulla C Gokhale, Brittaney A Leeper, Nicole S Persky, David E Root, Praju V Anekal, Pau...> ;Biorxiv. 2023 Aug 16
• 3 citations
  Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer.
  Rohit Thummalapalli, Biagio Ricciuti, Chaitanya Bandlamudi, Daniel Muldoon, Hira Rizvi, Arielle Elkrief, Jia Luo, Joao V Alessi, Federica Pecci, Giuseppe Lamberti, Ale...> ;Clinical Cancer Research. 2023 Nov 1
• Case report: Diagnosis of NUT carcinoma of hepatic origin by next-generation sequencing.
  Azqueta, J., Ardalan, B., Luo, J., French, C.> ;Frontiers in Oncology. 2023 Jan 1
• 1 citations
  Safety of image guided research biopsies in patients with thoracic malignancies.
  Steffan K Soosman, Matthew P Schenker, Emanuele Mazzola, Emma Voligny, Anna Smokovich, Camden Bay, Tom Nguyen, Kesi Michael, Pasi A Jänne, Michael Rabin, Daniel I Glaz...> ;Lung Cancer. 2022 Nov 1
• 5 citations
  Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas.
  Paul K Paik, Jia Luo, Ni Ai, Rachel Kim, Linda Ahn, Anup Biswas, Courtney Coker, Wanchao Ma, Phillip Wong, Darren J Buonocore, W Victoria Lai, Jamie E Chaft, Swarnali ...> ;Nature Communications. 2022 Oct 15
• 28 citations
  Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRAS-mutated non-small-cell lung cancer.
  B Ricciuti, J V Alessi, A Elkrief, X Wang, A Cortellini, Y Y Li, V R Vaz, H Gupta, F Pecci, A Barrichello, G Lamberti, T Nguyen, J Lindsay, B Sharma, K Felt, S J Rodig...> ;Annals of Oncology. 2022 Oct 1
• 63 citations
  Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer.
  Rami S Vanguri, Jia Luo, Andrew T Aukerman, Jacklynn V Egger, Christopher J Fong, Natally Horvat, Andrew Pagano, Jose de Arimateia Batista Araujo-Filho, Luke Geneslaw,...> ;Nature Cancer. 2022 Oct 1
• 16 citations
  Deciphering radiological stable disease to immune checkpoint inhibitors.
  J Luo, S Wu, H Rizvi, Q Zhang, J V Egger, J C Osorio, A J Schoenfeld, A J Plodkowski, M S Ginsberg, M K Callahan, C Maher, A N Shoushtari, M A Postow, M H Voss, R R Ko...> ;Annals of Oncology. 2022 Aug 1
• 13 citations
  High-Dose Osimertinib for CNS Progression in EGFR+ NSCLC: A Multi-Institutional Experience.
  A J Piper-Vallillo, Julia K Rotow, Jacqueline V Aredo, Khvaramze Shaverdashvili, Jia Luo, Jennifer W Carlisle, Hatim Husain, Alona Muzikansky, Rebecca S Heist, Deepa R...> ;JTO Clinical and Research Reports. 2022 Jun 1
• 8 citations
  Overcoming-Mutant Lung Cancer.
  Jia Luo, Jonathan Ostrem, Bruna Pellini, Denis Imbody, Yaakov Stern, Hitendra S Solanki, Eric B Haura, Liza C Villaruz> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2022 Apr 1
• 41 citations
  Beyond Steroids: Immunosuppressants in Steroid-Refractory or Resistant Immune-Related Adverse Events.
  Jia Luo, Jason A. Beattie, Paige Fuentes, Hira Rizvi, Jacklynn V. Egger, Jeffrey A. Kern, Donald Y.M. Leung, Mario E. Lacouture, Mark G. Kris, Maya Gambarin, Bianca Sa...> ;Journal of Thoracic Oncology. 2021 Jul 12
• 24 citations
  Immunotherapy-Mediated Thyroid Dysfunction: Genetic Risk and Impact on Outcomes with PD-1 Blockade in Non–Small Cell Lung Cancer
  Jia Luo, Victoria Martucci, Zoe Quandt, Stefan Groha, Megan H. Murray, Christine M. Lovly, Hira Rizvi, Jacklynn V. Egger, Andrew J. Plodkowski, Mohsen Abu-Akeel, Isabe...> ;Clinical Cancer Research. 2021 Sep 15
• 1 citations
  Association of prior radiation dose to the cardiopulmonary system with COVID-19 outcomes in patients with cancer.
  Quincey LaPlant, Maria Thor, Narek Shaverdian, Jacob Y Shin, Philip Gilbo, Jia Luo, Daniel R. Gomez, Daphna Y. Gelblum> ;Radiotherapy and Oncology. 2021 Jun 6
• 21 citations
  Success and failure of additional immune modulators in steroid-refractory/resistant pneumonitis related to immune checkpoint blockade.
  Jason Beattie, Hira Rizvi, Paige Fuentes, Jia Luo, Adam J. Schoenfeld, I-Hsin Lin, Michael A. Postow, Margaret K. Callahan, Martin H. Voss, Neil J. Shah, Allison Betof...> ;Journal for Immunotherapy of Cancer. 2021 Feb 1
• 9 citations
  Erlotinib and Trametinib in Patients With EGFR-Mutant Lung Adenocarcinoma and Acquired Resistance to a Prior Tyrosine Kinase Inhibitor
  Jia Luo, Alex Makhnin, Yosef Tobi, Linda Ahn, Sara A. Hayes, A. Iqbal, Kenneth K.-S. Ng, Maria E. Arcila, Gregory J Riely, Mark G. Kris, Helena A. Yu> ;JCO Precision Oncology. 2021 Jan 11
• 10 citations
  Predictors of postoperative biochemical remission in acromegaly
  Shun Yao, Wenli Chen, Sherwin Tavakol, Farhana Akter, Michael P Catalino, Xiao-Peng Guo, Jie Luo, Ailiang Zeng, Leo Zekelman, Zhigang Mao, Yonghong Zhu, Qing-Zhi Wu, E...> ;Journal of Neuro-Oncology. 2021 Jan 4
• Join now to see all

Journal Articles

• Role of p38γ MAPK in Regulation of EMT and Cancer Stem Cells  
  Jia Luo, MD, ScienceDirect